Doris Barcellona/Fondazione Arianna Anticoagulazione
Aug 22, 2025, 03:37
Lupus Anticoagulant-Hypoprothrombinemia Syndrome: Review by Doris Barcellona and Colleagues
Maria Filomena Ruberto, Biologist specialized in Clinical Pathology and Clinical Biochemistry and II Level Master’s degree in Hemostasis and Thrombosis, shared on LinkedIn:
”Doris Barcellona et al.Lupus Anticoagulant-hypoprothrombinemia Syndrome: A Review Enriched by a New Particular Patient. Semin Thromb Hemost. 2025.”
Read the full article here.
Article: Lupus Anticoagulant-hypoprothrombinemia Syndrome: A Review Enriched by a New Particular Patient
Authors: Doris Barcellona , Antonella Mameli , Roberta Montisci , Maria Filomena Ruberto , Lara Fenu , Francesco Marongiu
Stay updated on all scientific advances in the field of bleeding disorders with Hemostasis Today.
-
Feb 23, 2026, 12:10Peter Libby: hsCRP May Select Patients Who Can Benefit From Statins or Anti-inflammatory Therapy
-
Feb 23, 2026, 12:02Marios Georgakis: An Unprecedented for An Antithrombotic Therapy from OCEANIC-STROKE Trial
-
Feb 23, 2026, 11:37Charles Okyere Boadu: Blood Donation Helps Lower Your Risk of Stroke and Organ Damage
-
Feb 23, 2026, 11:29Emma Lefrancais: Uncovering A Key Role for The IL-33/ST2 Axis in Platelet Biology with Lucie Gelon
-
Feb 22, 2026, 14:16Ilenia Calcaterra: From Representation to Intellectual Independence in Women in Science
-
Feb 22, 2026, 13:27Pete Stibbs: New AHA and ACC PE Guidelines Finally Align with Real Clinical Practice
-
Feb 22, 2026, 10:39Tagreed Alkaltham: Fibrinogen Concentrate Is a Deliberate Clinical Choice in Acute Bleeding
-
Feb 22, 2026, 09:38Abdulrahman Nasiri: Significant Shifts In The 2026 AHA/ACC Guidelines for Acute Pulmonary Embolism
-
Feb 22, 2026, 09:22Shiny K. Kajal: Not All Transfusion Reactions Are Immunohematologic Incompatibilities